Supplementary Table 2 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes
Authors:
- Benedetta ConteBCBenedetta Conte
- Fara Brasó-MaristanyFBFara Brasó-Maristany
- Tomás PascualTPTomás Pascual
- Cristina HernandoCHCristina Hernando
- Silvia VázquezSVSilvia Vázquez
- Salvador BlanchSBSalvador Blanch
- Mafalda OliveiraMafalda Oliveira
- Juan Antonio VirizuelaJVJuan Antonio Virizuela
- Montserrat MuñozMMMontserrat Muñoz
- Elia SeguíESElia Seguí
- Adela Rodriguez-HernandezAdela Rodriguez-Hernandez
- Maria Jesus Vidal LosadaMLMaria Jesus Vidal Losada
Open Access
- 1 April 2026
- other
- Published by American Association for Cancer Research (AACR)